1.

The use of disease-specific outcome measures in cost-utility analysis: The development of Dutch societal preference weights for the FACT-L scale

1.

Integral costs of head and neck oncology (in Dutch)

1.

Real-world cost-effectiveness of cetuximab in the third-line treatment of metastatic colorectal cancer based on patient chart review in the Netherlands

1.

A cost of illness and equality of life study in patients with B-cell chronic lymphocytic leukemia (CLL) in the Netherlands

1.

Practice Variation in Skin Cancer Treatment and Follow-Up Care: A Dutch Claims Database Analysis

1.

Hospital-based or home-based administration of oncology drugs?

1.

Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands

1.

Cabazitaxel treatment in metastatic castration-resistant prostate cancer (mCRPC) clinical trials compared to usual care in CAPRI: An observational study in the Netherlands

1.

Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study

1.

Third-line Life-prolonging Drug Treatment in a Real-world Metastatic Castration-resistant Prostate Cancer Population: Results from the Dutch Castration-resistant Prostate Cancer Re...